Myasthenia gravis with ocular involvement in older patients

Canadian Journal of Ophthalmology

Volumn 36, Issue 1, 2001, Pages 26-33

  Weizer, Jennifer S ^a   Lee, Andrew G ^b   Coats, David K ^a  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Elderly; Myasthenia gravis

Indexed keywords

CHOLINESTERASE INHIBITOR; GLUCOCORTICOID; PREDNISONE;

AGED; ARTICLE; DRUG COMBINATION; EYE DISEASE; FEMALE; HUMAN; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; THYROID DISEASE;

AGED; AGED, 80 AND OVER; CHOLINESTERASE INHIBITORS; DRUG THERAPY, COMBINATION; EYE DISEASES; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; PREDNISONE; RETROSPECTIVE STUDIES; THYROID DISEASES;

EID: 0035259690     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: 10.1016/S0008-4182(01)80063-6     Document Type: Article

References (30)

1. Monden Y, Nakahara K, Fujii Y, Hashimoto J, Ohno K, Masaoka A, et al. Myasthenia gravis in elderly patients. Ann Thorac Surg 1985;39:433-6.
2. Osserman KE, Genkins G. Studies in myasthenia gravis: review of a twenty-year experience in over 1200 patients. Mt Sinai J Med 1971;38:497-537.
3. Robertson NP, Deans J, Compston DA. Myasthenia gravis: a population based epidemiological study in Cambridgeshire, England. J Neurol Neurosurg Psychiatry 1998;65: 492-6.
4. Storm-Mathisen A. Epidemiology of myasthenia gravis in Norway. Acta Neurol Scand 1984;70:274-84.
5. Rivero A, Crovetto L, Lopez L, Maselli R, Nogues M. Single fiber electromyography of extraocular muscles: a sensitive method for the diagnosis of ocular myasthenia gravis. Muscle Nerve 1995;18:943-7.
6. Bever CT Jr, Aquino AV, Penn AS, Lovelace RE, Rowland LP. Prognosis of ocular myasthenia. Ann Neurol 1983;14:516-9.
7. Evoli A, Tonali P, Bartoccioni E, Lo Monaco M. Ocular myasthenia: diagnostic and therapeutic problems. Acta Neurol Scand 1988;77:31-5.
8. Grob D, Arsura EL, Brunner NG, Namba T. The course of myasthenia gravis and therapies affecting outcome. Ann N Y Acad Sci 1987;505:472-99.
9. Beekman R, Kuks JB, Oosterhuis HJ. Myasthenia gravis: diagnosis and follow-up of 100 consecutive patients. J Neurol 1997;244:112-8.
10. Sommer N, Sigg B, Melms A, Weller M, Schepelmann K, Herzau V, et al. Ocular myasthenia gravis: response to long-term immunosuppressive treatment. J Neurol Neurosurg Psychiatry 1997;62:156-62.
11. Kupersmith MJ, Moster M, Bhuiyan S, Warren F, Weinberg H. Beneficial effects of corticosteroids on ocular myasthenia gravis. Arch Neurol 1996;53:802-4.
12. Oosterhuis HJ. The natural course of myasthenia gravis: a long term follow up study. J Neurol Neurosurg Psychiatry 1989;52:1121-7.
13. Ohtsuki H, Hasebe S, Okano M, Furuse T. Strabismus surgery in ocular myasthenia gravis. Ophthalmologica 1996;210:95-100.
14. Olanow CK, Lane JM, Roses AD. Thymectomy in late-onset myasthenia gravis. Arch Neurol 1982;39:82-3.
15. Antonini G, Morino S, Gragnani F, Fiorelli M. Myasthenia gravis in the elderly: a hospital based study. Acta Neurol Scand 1996;93:260-2.
16. Schlezinger NS, Fairfax WA. Evaluation of ocular signs and symptoms in myasthenia gravis. Arch Ophthalmol 1959;62:985-90.
17. Kaminski HJ. Acetylcholine receptor epitopes in ocular myasthenia. Ann N YAcad Sci 1998;841:309-19.
18. Uyama J, Mimura O, Ikeda N, Shimo-Oku M. Single-fiber electromyography of extraocular muscles in myasthenia gravis. Neuroophthalmology 1993;13:253-61.
19. MacLennan C, Beeson D, Buijs AM, Vincent A, Newsom-Davis J. Acetylcholine receptor expression in human extraocular muscles and their susceptibility to myasthenia gravis. Ann Neurol 1997;41:423-31.
20. Oda K. Differences in acetylcholine receptor-antibody interactions between extraocular and extremity muscle fibers. Ann N Y Acad Sci 1993;681:238-55.
21. Oda K, Shibasaki H. Antigenic difference of acetylcholine receptor between single and multiple form endplates of human extraocular muscle. Brain Res 1988;449: 337-40.
22. Compston DA, Vincent A, Newsom-Davis J, Batchelor JR. Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis. Brain 1980;103:579-601.
23. Garlepp MJ, Dawkins RL, Christiansen FT, Lawton J, Luciani G, McLeod J, et al. Autoimmunity in ocular and generalised myasthenia gravis. J Neuroimmunol 1981;1: 325-32.
24. Gunji K, Skolnick C, Bednarczuk T, Benes S, Ackrell BA, Cochran B, et al. Eye muscle antibodies in patients with ocular myasthenia gravis: possible mechanism for eye muscle inflammation in acetylcholine-receptor antibody-negative patients. Clin Immunol Immunopathol 1998;87: 276-81.
25. Marino M, Ricciardi R, Pinchera A, Barbesino G, Manetti L, Chiovato L, et al. Mild clinical expression of myasthenia gravis associated with autoimmune thyroid diseases. J Clin Endocrinol Metab 1997;82:438-43.
26. Sanders DB, Howard JF. Single fiber electromyography in myasthenia gravis. Muscle Nerve 1986;9:809-19.
27. Soliven BC, Lange DJ, Penn AS, Younger D, Jaretzki A III, Lovelace RE, et al. Seronegative myasthenia gravis. Neurology 1988;38:514-7.
28. Nakamura H, Taniguchi Y, Suzuki Y, Tanaka Y, Ishiguro K, Fukuda M, et al. Delayed remission after thymectomy for myasthenia gravis of the purely ocular type. J Thorac Cardiovasc Surg 1996;112:371-5.
29. Simpson JA. Myasthenia gravis as an autoimmune disease: clinical aspects. Ann N Y Acad Sci 1966;135:506-16.
30. Oosterhuis HJ. Observations of the natural history of myasthenia gravis and the effect of thymectomy. Ann N Y Acad Sci 1981;377:678-90.